Latest filing published 17 Jun 2025 for KALA BIO, Inc.. Read the official filing
No signal scores available.
Marjan Farid discloses dealings in KALA BIO, Inc. to SEC (Form 4). Between 31 May 2023 and 15 June 2025, the trades on record add up to 4 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 17 June 2025 came the latest disclosure, a share grant in KALA BIO, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations